Brief: Radiopharm Theranostics Says Entered Into Clinical Supply Agreement
Oct 26 (Reuters) - Radiopharm Theranostics Ltd RAD.AX :
* ENTERED INTO CLINICAL SUPPLY AGREEMENT THAT WILL SEE
NORTHSTAR
SUPPLY RADIOPHARM WITH ACTINIUM-225
* INITIAL ORDER WITH NORTHSTAR EXPECTED TO OCCUR DURING
FIRST HALF
OF 2024
* COSTS ASSOCIATED WITH PURCHASE OF ACTINIUM-225 NOT
MATERIAL FOR
CO'S ANNUAL BUDGETED EXPENDITURE
Source text for Eikon: ID:nASX9djC8p
Further company coverage: RAD.AX
Recent news on Radiopharm Theranostics
See all newsNASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Radiopharm Theranostics To Meet With U.S. FDA To Align On Pivotal Phase 3 Trial Design For Rad 101 In Diagnosis Of Brain Metastases
NASDAQ RESUMED AT 09:56 AM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:50 AM